Ross Moat

Insider Reports History

Location
C/O Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Aaron Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ross Moat:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Performance Share Unit 5.23K $351K $17.88 May 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Class A Ordinary Share 9.42K $332K $35.31 Sep 4, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Share Option 39.4K Sep 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Performance Share Option 8.3K May 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Restricted Share Unit 0 Sep 2, 2025 Direct

Insider Reports Filed by Ross Moat

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc Sep 4, 2025 1 -$124K 4 Sep 8, 2025 CHIEF CORP. & COMM. OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Sep 1, 2025 12 -$111K 4 Sep 3, 2025 CHIEF CORP. & COMM. OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Jun 3, 2025 3 -$432K 4 Jun 5, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc May 1, 2025 10 -$104K 4 May 5, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 29, 2025 18 -$1.09M 4 May 1, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 21, 2025 1 -$370K 4 Apr 23, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 7, 2025 3 -$14.7K 4 Apr 9, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 1, 2025 9 -$21.4K 4 Apr 3, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 16, 2025 4 $11.3K 4 Mar 19, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Jul 15, 2024 18 -$1.08M 4 Sep 4, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 4, 2024 6 -$24.2K 4 Apr 8, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2024 3 -$17.3K 4 Apr 3, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2023 9 -$30.1K 4 Sep 6, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 10, 2023 3 -$14.5K 4 Apr 11, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2023 2 $0 4 Apr 3, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jan 15, 2023 7 -$1.57K 4 Mar 20, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2022 6 -$3K 4 Sep 6, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 7, 2022 2 $0 4 Apr 11, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 21, 2022 3 -$13.6K 4 Mar 23, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 ARCALYST General Manager
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2021 5 $20.4K 4 Mar 18, 2022 Chief Commercial Officer